Stephen Brozak
Stock Analyst at WBB Securities
(2.98)
# 1,492
Out of 4,732 analysts
9
Total ratings
100%
Success rate
30.35%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Brozak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics | Maintains: Strong Buy | $40 → $45 | $21.70 | +107.37% | 6 | Dec 5, 2024 | |
| ARCT Arcturus Therapeutics Holdings | Downgrades: Hold | $31 | $16.79 | +84.63% | 2 | Jun 9, 2020 | |
| PATH UiPath | Upgrades: Strong Buy | n/a | $13.02 | - | 1 | Jan 22, 2013 |
Cidara Therapeutics
Dec 5, 2024
Maintains: Strong Buy
Price Target: $40 → $45
Current: $21.70
Upside: +107.37%
Arcturus Therapeutics Holdings
Jun 9, 2020
Downgrades: Hold
Price Target: $31
Current: $16.79
Upside: +84.63%
UiPath
Jan 22, 2013
Upgrades: Strong Buy
Price Target: n/a
Current: $13.02
Upside: -